Prevalence of HTLV-III/LAV Antibodies among Haitians

Arthur E. Pitchenik, Thomas J. Spira, Robert Elie, Margaret A. Fischl, Jane P. Getchell, Emmanuel Arnoux, Gerard D. Pierre, A. Claude Laroche, Jean Michel Guerin, Rodolphe Malebranche

Research output: Contribution to journalLetter

5 Scopus citations

Abstract

To the Editor: The prevalence of antibodies to the human T-cell lymphotropic virus Type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been reported in various groups at increased risk for the acquired immunodeficiency syndrome (AIDS)1: 22 to 65 per cent in homosexual men, 87 per cent in intravenous drug abusers admitted to a detoxification program in New York City, and 56 to 72 per cent in persons with hemophilia A. Although persons born in Haiti have been considered to be at increased risk for AIDS, the prevalence of antibodies to HTLV-III/LAV has not been reported among randomly selected Haitian populations living in.

Original languageEnglish (US)
Pages (from-to)1705-1706
Number of pages2
JournalNew England Journal of Medicine
Volume312
Issue number26
DOIs
StatePublished - Jun 27 1985

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevalence of HTLV-III/LAV Antibodies among Haitians'. Together they form a unique fingerprint.

  • Cite this

    Pitchenik, A. E., Spira, T. J., Elie, R., Fischl, M. A., Getchell, J. P., Arnoux, E., Pierre, G. D., Laroche, A. C., Guerin, J. M., & Malebranche, R. (1985). Prevalence of HTLV-III/LAV Antibodies among Haitians. New England Journal of Medicine, 312(26), 1705-1706. https://doi.org/10.1056/NEJM198506273122609